Comparative bioavailability of acyclovir from oral valacyclovir and acyclovir in patients treated for recurrent genital herpes simplex virus infection

Canadian Journal of Clinical Pharmacology

Volumn 8, Issue 4, 2001, Pages 207-211

  Alvaro, P M ^a   Sitar, Daniel S ^a   Aoki, Fred Y ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Acyclovir; Bioavailability; Sex; Valacyclovir

Indexed keywords

ACICLOVIR; PLACEBO; VALACICLOVIR;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; DOUBLE BLIND PROCEDURE; DRUG BIOAVAILABILITY; DRUG EXCRETION; DRUG FORMULATION; DRUG URINE LEVEL; FEMALE; GENITAL HERPES; HERPES SIMPLEX VIRUS; HUMAN; MALE; RANDOMIZED CONTROLLED TRIAL;

EID: 0035682521     PISSN: 1198581X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Acylovir: A decade later
2. Pharmacokinetics of acyclovir after intravenous and oral administration
3. Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single- and multiple-dose administration to normal volunteers
4. A randomized, placebo-controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections
5. Valaciclovir versus acyclovir in patient-initiated treatment of recurrent genital herpes: A randomized, double blind clinical trial
6. Rapid determination of acyclovir in plasma by reverse phase high performance liquid chromatography
7. Prediction of creatinine clearance from serum creatinine
8. Acyclovir: A reappraisal of its antiviral activity, pharmacokinetics and therapeutic efficacy
9. Absolute bioavailability and metabolic disposition of valaciclovir, the 1-valyl ester of acyclovir, following oral administration to humans
10. Acyclovir. A review of its pharmacodynamic properties and therapeutic efficacy